CJC-1295 + Ipamorelin
GRF analog + GHS pentapeptide · combined-axis research
ALO-P-023-10MG · In stock
Ordering 10+ vials of CJC-1295 + Ipamorelin? 10+ vials of one compound are 40% off that compound, and 50+ vials are 50% off the whole order — confirmed on your order before payment.
For laboratory research use only. Not for human or veterinary use. Not a drug, food, supplement or cosmetic, and not intended to diagnose, treat, cure or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
- Lot number printed on every vial
- Each lot gets its own public record
- Purity by RP-HPLC, identity by mass spec
- Volume pricing from 10 vials
CJC-1295 (No DAC) + Ipamorelin combines the modified GRF(1-29) analog and the selective growth-hormone-secretagogue pentapeptide in a single equal-parts vial (the 10 mg vial contains 5 mg of each), supplied lyophilized for laboratory research on combined GHRH/GHSR-pathway signaling. Each lot ships against an independent analytical record in the COA directory.
For combined GHRH-receptor and ghrelin-receptor pathway models, co-signaling assays, and comparative secretagogue studies under institutional research protocols.
- Catalog code
- ALO-P-023
- Form
- Lyophilized powder
- Classification
- Research peptide — laboratory use only
Store lyophilized at −20°C. Protect from light and moisture.
Handle using standard laboratory PPE and aseptic technique. Reconstitute only under controlled research conditions.
Laboratory handling guide →Sold strictly for in-vitro laboratory research by qualified purchasers aged 21 or older. We don’t provide dosing, administration or human-use guidance.
Read the research-use policy →
